Korro Bio, Inc.
KRRO
$13.28
-$0.01-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 1.29M | 1.09M | 1.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 1.29M | 1.09M | 1.46M |
| Cost of Revenue | 11.63M | 11.53M | 8.60M | 11.26M | 17.46M |
| Gross Profit | -11.63M | -11.53M | -7.31M | -10.17M | -16.00M |
| SG&A Expenses | 8.48M | 8.91M | 8.58M | 9.06M | 9.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.11M | 20.44M | 17.18M | 20.33M | 27.43M |
| Operating Income | -20.11M | -20.44M | -15.88M | -19.24M | -25.97M |
| Income Before Tax | -18.81M | -19.53M | -49.41M | -18.06M | -25.77M |
| Income Tax Expenses | 108.00K | 95.00K | 636.00K | -- | 1.00K |
| Earnings from Continuing Operations | -18.92M | -19.63M | -50.04M | -18.06M | -25.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.92M | -19.63M | -50.04M | -18.06M | -25.77M |
| EBIT | -20.11M | -20.44M | -15.88M | -19.24M | -25.97M |
| EBITDA | -19.75M | -20.06M | -15.23M | -18.06M | -24.74M |
| EPS Basic | -1.07 | -1.69 | -5.32 | -1.92 | -2.74 |
| Normalized Basic EPS | -0.67 | -1.05 | -0.99 | -1.20 | -1.63 |
| EPS Diluted | -1.07 | -1.69 | -5.32 | -1.92 | -2.74 |
| Normalized Diluted EPS | -0.67 | -1.05 | -0.99 | -1.20 | -1.63 |
| Average Basic Shares Outstanding | 17.62M | 11.60M | 9.42M | 9.39M | 9.39M |
| Average Diluted Shares Outstanding | 17.62M | 11.60M | 9.42M | 9.39M | 9.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |